title: [Specific damage of ocular and orbital structures in sarcoidosis].
abstract: Complex damage of ocular and orbital structures is an important manifestation of sarcoidosis. Incidence of ocular sarcoidosis varies among the different groups of patients. Nevertheless all patients should undergo specific examination of eye and orbit. Delayed diagnosis of ocular sarcoidosis and improper treatment may result in severe complications. Orbital changes should be also revealed in time and properly evaluated. These are the reasons for searching of new methods of eye and orbit examination in patients with sarcoidosis.
authors.forename: S I
authors.initials: SI
authors.lastname: Kharlap
authors.forename: O V
authors.initials: OV
authors.lastname: Éksarenko
authors.forename: T A
authors.initials: TA
authors.lastname: Shchegoleva
authors.forename: É A
authors.initials: ÉA
authors.lastname: Vashkulatova
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D003941:Diagnostic Techniques, Ophthalmological; D019468:Disease Management; D018450:Disease Progression; D061345:Early Medical Intervention; D005123:Eye / Q000473:pathology / Q000503:physiopathology; D005128:Eye Diseases / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D009915:Orbit / Q000473:pathology / Q000503:physiopathology; D011379:Prognosis; D012507:Sarcoidosis / Q000150:complications*; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D061067:Antibodies, Monoclonal, Humanized; D000964:Antimetabolites, Antineoplastic; D005938:Glucocorticoids